Hari Shankar and Om Prakash Shukla upheld a December 2025 single-judge order, observing that Novo Nordisk's species patent appeared "susceptible to revocation on grounds of obviousness." The court noted that semaglutide would be obvious from teachings contained in Novo's earlier genus patent, which expired in 2024
The Challenge GLP-1s are an important new tool for weight loss but as with any tool, they have their limitations
Rivera FB, Cruz LLA, Magalong JV, et al
Patients with certain genetic profiles may experience more severe GI symptoms or differential weight loss patterns
She clarified that while experts don't classify food noise as a formal medical diagnosis, researchers can absolutely measure the experience behind it, using surveys that track food cravings, how often people think about food, and how hard it is to resist
Weve seen some impressive results and would love to help you achieve the same if youre the right fit for these injections